We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Allergan Plc | LSE:0Y7T | London | Ordinary Share | IE00BY9D5467 | ALLERGAN ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 154.21 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDM0Y7T
RNS Number : 7065W
BlackRock Group
12 December 2019
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION Name of person dealing BlackRock, Inc. (Note 1) Company dealt in Allergan plc ========================= Class of relevant security US$0.0001 ordinary shares to which the dealings being disclosed relate (Note 2) ========================= Date of dealing 11 December 2019 ========================= 2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long Short Number (%) Number (%) =========== ======= =========== ====== (1) Relevant securities 20,849,443 (6.34%) 44,108 (0.01%) ==================== =================== (2) Derivatives (other than options) 4,229,811 (1.28%) 37,599 (0.01%) ==================== =================== (3) Options and agreements to purchase/sell 0 (0.00%) 0 (0.00%) ==================== =================== Total 25,079,254 (7.63%) 81,707 (0.02%) ==================== ===================
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short Number (%) Number (%) ========= ====== =========== ====== (1) Relevant securities =================== ===================== (2) Derivatives (other than options) =================== ===================== (3) Options and agreements to purchase/sell =================== ===================== Total =================== =====================
Ap20
1. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of relevant securities Price per unit (Note 5) Purchase 2,599 USD 186.1396 ====================================== ==================== Purchase 554 USD 186.3735 ====================================== ==================== Purchase 591 USD 186.5103 ====================================== ==================== Purchase 30 USD 186.5600 ====================================== ==================== Purchase 11,040 USD 186.6400 ====================================== ==================== Purchase 930 USD 186.5373 ====================================== ==================== Sale 436 USD 186.4613 ====================================== ==================== Sale 130 USD 186.4895 ====================================== ==================== Sale 4,305 USD 186.6400 ====================================== ====================
Please note: there was also a Transfer In of 4,382 Shares
(b) Derivatives transactions (other than options transactions) Product Nature of transaction Number of relevant Price per name, (Note 6) securities unit e.g. CFD (Note 7) (Note 5) CFD Reducing Short 80 USD 186.5094 ===================== ================== ============ CFD Reducing Short 1,360 USD 186.5227 ===================== ================== ============ CFD Reducing Long 16 USD 186.3344 ===================== ================== ============ (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, Expiry Option name, selling, securities price e.g. American, date money paid/received e.g. call purchasing, to which European per unit option varying the option etc. (Note 5) etc. relates (Note 7) (ii) Exercising Product name, Number of securities Exercise price e.g. call option per unit (Note 5) (d) Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) Return of Stock 221 N/A on Loan ============== ====================
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities
to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 12 December 2019 Contact name Jana Blumenstein ================ Telephone number +44 20 7743 3650 ================ If a connected EFM, name of offeree/offeror with which connected ================ If a connected EFM, state nature of connection (Note 10) ================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ISEGGGGGPUPBGPP
(END) Dow Jones Newswires
December 12, 2019 10:20 ET (15:20 GMT)
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions